[go: up one dir, main page]

PL401911A1 - Use of the preparation with the immunoregulatory properties - Google Patents

Use of the preparation with the immunoregulatory properties

Info

Publication number
PL401911A1
PL401911A1 PL401911A PL40191112A PL401911A1 PL 401911 A1 PL401911 A1 PL 401911A1 PL 401911 A PL401911 A PL 401911A PL 40191112 A PL40191112 A PL 40191112A PL 401911 A1 PL401911 A1 PL 401911A1
Authority
PL
Poland
Prior art keywords
preparation
immunoregulatory properties
immunoregulatory
therapy
disorders
Prior art date
Application number
PL401911A
Other languages
Polish (pl)
Other versions
PL217193B1 (en
Inventor
Marta Jakubik
Joanna Rymaszewska
Antoni Polanowski
Tadeusz Trziszka
Original Assignee
Uniwersytet Przyrodniczy We Wroclawiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Przyrodniczy We Wroclawiu filed Critical Uniwersytet Przyrodniczy We Wroclawiu
Priority to PL401911A priority Critical patent/PL217193B1/en
Publication of PL401911A1 publication Critical patent/PL401911A1/en
Publication of PL217193B1 publication Critical patent/PL217193B1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Wynalazek dotyczy zastosowania preparatu immunoregulatorowego pozyskanego z zóltka jaja do wytwarzania srodka farmaceutycznego, zwlaszcza suplementu diety, do stosowania w profilaktyce zaburzen funkcji poznawczych o róznym podlozu i/lub wspomagajaco w terapii tych zaburzen, zwlaszcza u chorych z niezadowalajaca odpowiedzia na konwencjonalna terapie.The invention relates to the use of an immunoregulatory preparation obtained from egg yolk for the production of a pharmaceutical, in particular a dietary supplement, for use in the prevention of cognitive disorders of various origins and/or as an aid in the therapy of these disorders, especially in patients with an unsatisfactory response to conventional therapy.

PL401911A 2012-12-05 2012-12-05 Use of the preparation with the immunoregulatory properties PL217193B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL401911A PL217193B1 (en) 2012-12-05 2012-12-05 Use of the preparation with the immunoregulatory properties

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL401911A PL217193B1 (en) 2012-12-05 2012-12-05 Use of the preparation with the immunoregulatory properties

Publications (2)

Publication Number Publication Date
PL401911A1 true PL401911A1 (en) 2013-08-19
PL217193B1 PL217193B1 (en) 2014-06-30

Family

ID=48951787

Family Applications (1)

Application Number Title Priority Date Filing Date
PL401911A PL217193B1 (en) 2012-12-05 2012-12-05 Use of the preparation with the immunoregulatory properties

Country Status (1)

Country Link
PL (1) PL217193B1 (en)

Also Published As

Publication number Publication date
PL217193B1 (en) 2014-06-30

Similar Documents

Publication Publication Date Title
TN2015000278A1 (en) Autotaxin inhibitors
PH12013502240B1 (en) Novel compounds as modulators of protein kinase
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
IL236221A (en) Thienopyridone derivatives and pharmaceutical compositions comprising them for the treatment of diseases
MX343687B (en) Tricyclic sulfonamide compounds and methods of making and using same.
WO2014176128A3 (en) Compositions and methods for the therapy and diagnosis of influenza
HK1207306A1 (en) Modified polynucleotides for the production of proteins associated with human disease
NZ702977A (en) 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof
EP4324527A3 (en) Formulations of enzalutamide
MX2014008705A (en) Tricyclic sulfone compounds and methods of making and using same.
MX343688B (en) Tricyclic pyrazole sulfonamide compounds and methods of making and using same.
IL231536A (en) Indazole-3-carboxamides , pharmaceutical compositions comprising them and their use in the treatment of diseases
MX2014008706A (en) Tricyclic sulfonamide compounds and methods of making and using same.
MX2015016741A (en) Dual selective pi3 delta and gamma kinase inhibitors.
EP4414376A3 (en) Novel depsipeptide and uses thereof
MX2018002546A (en) COMPOSITIONS THAT INCLUDE A UROLITINE COMPOUND.
GT201400161A (en) PHENYLIMIDAZOPIRAZOLES REPLACED AND ITS USE
TN2016000107A1 (en) Substituted phenylalanine derivatives
BR112015011759A2 (en) symbiotic composition and use of it
MX2015005732A (en) Tricyclic compounds and methods of making and using same.
MX2016006544A (en) Withanolides useful for the treatment of neurodegenerative diseases.
EA201491426A1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING PHOSPHATIDILSERIN AND CURKUMIN
BR112015005268A2 (en) syringe containing a composition, in particular pharmaceutical, composed of immunoglobulins, their method of manufacture and their use
MX362854B (en) Sirna and their use in methods and compositions for the treatment and/or prevention of eye conditions.
MX2015005733A (en) Tricyclic compounds for use in the treatment and/or control of obesity.